Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

List of clinical trials for Phase I highest development status

Phase I

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Contact Supplier

Jai Radhe Sales is your partner for all your sourcing needs.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

Contact Supplier

Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Filters

FILTER :

filter Interventions

All

Exenatide

filter Therapeutic Area

All

Endocrinology

filter Condition

All

Type 2 diabetes mellitus

filter Study Phase

All

Phase I

filter Location

All

Blank

Oramed Pharmaceuticals

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

U.s.a

Digital Content

Single-blind, placebo-controlled, crossover study to evaluate safety in addition to the pharmacokinetics of ORMD-0901 compared to placebo an...

Highest Development Status: Phase I

Therapeutic Area: Endocrinology

Interventions: Exenatide

Product Type: Large molecule

Sponsor: Oramed Inc

Receptors: Glucagon-like peptide 1 recept...

Trial ID: NA

Location: NA

Condition: Type 2 diabetes mellitus

Product Status: Approved

Dosage Form: Capsule

Collaborator: NA

Recruitment Status: NA

Date Of Registration: NA

Product Description: ORMD-0901 (Exenatide), a GLP-1 analog, is based on Oramed

01

Oramed Pharmaceuticals

U.S.A

BioFlorida Conference

Not Confirmed

Oramed Pharmaceuticals

U.S.A

BioFlorida Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Highest Development Status: Phase I

Therapeutic Area: Endocrinology

Interventions: Exenatide

Location: NA

Sponsor: Oramed Inc

Trial ID: NA

Single-blind, placebo-controlled, crossover study to evaluate safety in addition to the pharmacokinetics of ORMD-0901 compared to placebo and to open label Byetta

Product Description: ORMD-0901 (Exenatide), a GLP-1 analog, is based on Oramed

Product Status: Approved

Dosage Form: Capsule

Collaborator: NA

Recruitment Status: NA

Date Of Registration: NA

Condition: Type 2 diabetes mellitus

Product Type: Large molecule

Receptors: Glucagon-like peptide 1 receptor agoni...

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

First

Last